Prosecution Insights
Last updated: October 04, 2026

Attends Healthcare Products Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Attends Healthcare Products Inc. manages a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently has 1 pending office action. This workload is assigned to the distinct examiner, which shows a focused prosecution path at the USPTO. This concentration allows the applicant to focus resources on a single point of contact during the examination process.

The busiest examiner for this portfolio is RASSAVONG, ERIC, who is responsible for the pending office action. Since this matches the total active count, this examiner is the only individual currently reviewing the company's applications. This concentration means that the prosecution strategy is entirely dependent on the feedback and procedural preferences of RASSAVONG, ERIC.

Furthermore, the portfolio's active matters are located within 1 distinct art unit. This indicates that the technical subject matter is currently being evaluated within a single specialized group. For a practitioner, having only this 1 distinct art unit involved simplifies the management of the portfolio, as there is no need to navigate different procedural norms or examination styles across multiple units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RASSAVONG, ERIC 1 71.6% +34.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16948163 SYNTHETIC SURFACTANT-FREE FINISH, SHEET HAVING SYNTHETIC SURFACTANT-FREE FINISH, ARTICLES HAVING SHEET WITH SYNTHETIC SURFACTANT-FREE FINISH, AND RELATED METHODS RASSAVONG, ERIC —

Top Art Units

Art UnitApps
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
16948163 SYNTHETIC SURFACTANT-FREE FINISH, SHEET HAVING SYNTHETIC SURFACTANT-FREE FINISH, ARTICLES HAVING SHEET WITH SYNTHETIC SURFACTANT-FREE FINISH, AND RELATED METHODS RASSAVONG, ERIC 3781 §103Other Final Rejection — Pending Sep 04, 2020

Managing Attends Healthcare Products Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month